Chinese Journal of Cancer Biotherapy
Impact Factor & Key Scientometrics

Chinese Journal of Cancer Biotherapy
Overview

Impact Factor

NA

H Index

5

Impact Factor

0.057

I. Basic Journal Info

Country

China
Journal ISSN: 1007385X
Publisher: Editorial office of Chinese Journal of Cancer Biotherapy
History: 2008-2011, 2013-2016, 2018-2022
Journal Hompage: Link
How to Get Published:

Research Categories

Scope/Description:

CJCB is dedicated to report the laboratory and clinical breakthroughs in the field of cancer biotherapy in China focusing on the new theories new techniques new methods and new drugs concerning the following areas gene therapy of tumors vaccine development antibody treatment small molecule targeted therapy and immune cells and cytokine treatment etc.CJCB also publicizes the strategies and policies of Chinese government on cancer biotherapy introduces the new development of cancer biotherapy in the world and thus CJCB has become a showcase of scientific advancement in the area of cancer biotherapy in China and an important flat for communication and cooperation between those involved in the area.

II. Science Citation Report (SCR)



Chinese Journal of Cancer Biotherapy
SCR Impact Factor

Chinese Journal of Cancer Biotherapy
SCR Journal Ranking

Chinese Journal of Cancer Biotherapy
SCImago SJR Rank

SCImago Journal Rank (SJR indicator) is a measure of scientific influence of scholarly journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from.

Chinese Journal of Cancer Biotherapy
Scopus 2-Year Impact Factor Trend

Note: impact factor data for reference only

Chinese Journal of Cancer Biotherapy
Scopus 3-Year Impact Factor Trend

Note: impact factor data for reference only

Chinese Journal of Cancer Biotherapy
Scopus 4-Year Impact Factor Trend

Note: impact factor data for reference only

Chinese Journal of Cancer Biotherapy
Impact Factor History

2-year 3-year 4-year
  • 2022 Impact Factor
    0.064 0.06 0.059
  • 2021 Impact Factor
    0.057 0.059 0.059
  • 2020 Impact Factor
    0.047 0.047 0.051
  • 2019 Impact Factor
    0.052 0.052 0.049
  • 2018 Impact Factor
    0.08 0.08 0.067
  • 2017 Impact Factor
    0.028 0.035 0.039
  • 2016 Impact Factor
    0.033 0.047 0.047
  • 2015 Impact Factor
    0.036 0.036 0.033
  • 2014 Impact Factor
    0.008 NA NA
  • 2013 Impact Factor
    0.009 NA NA
  • 2012 Impact Factor
    0.008 NA NA
  • 2011 Impact Factor
    0.042 NA NA
  • 2010 Impact Factor
    0.031 NA NA
  • 2009 Impact Factor
    0.07 NA NA
  • 2008 Impact Factor
    0 NA NA
  • 2007 Impact Factor
    NA NA NA
  • 2006 Impact Factor
    NA NA NA
  • 2005 Impact Factor
    NA NA NA
  • 2004 Impact Factor
    NA NA NA
  • 2003 Impact Factor
    NA NA NA
  • 2002 Impact Factor
    NA NA NA
  • 2001 Impact Factor
    NA NA NA
  • 2000 Impact Factor
    NA NA NA
Note: impact factor data for reference only

HIGHEST PAID JOBS

LATEX TUTORIALS

MUST-READ BOOKS


Impact Factor

Impact factor (IF) is a scientometric factor based on the yearly average number of citations on articles published by a particular journal in the last two years. A journal impact factor is frequently used as a proxy for the relative importance of a journal within its field. Find out more: What is a good impact factor?


III. Other Science Influence Indicators

Any impact factor or scientometric indicator alone will not give you the full picture of a science journal. There are also other factors such as H-Index, Self-Citation Ratio, SJR, SNIP, etc. Researchers may also consider the practical aspect of a journal such as publication fees, acceptance rate, review speed. (Learn More)

Chinese Journal of Cancer Biotherapy
H-Index

The h-index is an author-level metric that attempts to measure both the productivity and citation impact of the publications of a scientist or scholar. The index is based on the set of the scientist's most cited papers and the number of citations that they have received in other publications

5

Chinese Journal of Cancer Biotherapy
H-Index History